BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30145665)

  • 1. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
    Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
    Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
    McEvoy CR; Seshadri R; Morley AA; Firgaira FA
    Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
    Ryschich E; Cebotari O; Fabian OV; Autschbach F; Kleeff J; Friess H; Bierhaus A; Büchler MW; Schmidt J
    Tissue Antigens; 2004 Dec; 64(6):696-702. PubMed ID: 15546343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
    Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
    Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
    Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
    Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
    Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.
    Yeung JT; Hamilton RL; Ohnishi K; Ikeura M; Potter DM; Nikiforova MN; Ferrone S; Jakacki RI; Pollack IF; Okada H
    Clin Cancer Res; 2013 Apr; 19(7):1816-26. PubMed ID: 23401227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
    del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
    Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
    Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
    Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.
    McEvoy CR; Morley AA; Firgaira FA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):321-5. PubMed ID: 12759931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
    Jordanova ES; Riemersma SA; Philippo K; Schuuring E; Kluin PM
    Int J Cancer; 2003 Jan; 103(3):393-8. PubMed ID: 12471623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
    Maleno I; Lopez Nevot MA; Seliger B; Garrido F
    Int J Cancer; 2004 Apr; 109(4):636-8. PubMed ID: 14991587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
    Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
    Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
    Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
    Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
    Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
    Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria to define HLA haplotype loss in human solid tumors.
    Ramal LM; Feenstra M; van der Zwan AW; Collado A; Lopez-Nevot MA; Tilanus M; Garrido F
    Tissue Antigens; 2000 May; 55(5):443-8. PubMed ID: 10885565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.